Skip to main content
PEGASUS MERCANTILE INC. logo

PEGASUS MERCANTILE INC. — Investor Relations & Filings

Ticker · LOAN ISIN · CA70557Y2042 LEI · 529900BGK3BYC4VSF690 CSE Financial and insurance activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2020-09-01 Regulatory Filings
Country CA Canada
Listing CSE LOAN

About PEGASUS MERCANTILE INC.

https://xtacytherapeutics.com/

Pegasus Mercantile Inc. is a diversified venture capital firm and prospect generator that provides financial, operational, and management assistance to high-growth companies. The firm specializes as an incubator for early-stage investments within the wellness consumer goods market, focusing on biotechnology, hemp, CBD, functional mushrooms, and psychedelics. Its investment strategy targets solutions for chronic pain, depression, and mental illness, often utilizing pioneering techniques such as micro-dosing organic and synthetic compounds. Pegasus Mercantile assists portfolio companies from startup through commercialization, specializing in navigating complex regulatory requirements, including clinical trials, patenting, and legislative approvals. The firm also provides debt financing facilities.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification form titled 'Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate' signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended June 30, 2020. The document explicitly states it is a certification of interim filings, not the filings themselves. It contains no actual financial data or substantive financial analysis but is an officer attestation regarding the interim filings. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself. The document length is short (2981 characters), consistent with a certification letter rather than a full report.
2020-09-01 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management's Discussion and Analysis' (MD&A) for the nine months ended June 30, 2020 and 2019. It contains detailed management commentary on financial condition, operational results, business description, outlook, going concern assessment, and specific investment details. The presence of substantive financial data and analysis for a period shorter than a full fiscal year (nine months) aligns with the characteristics of an Interim / Quarterly Report. The document is lengthy (15,000 characters) and contains actual financial and operational information, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2020
2020-09-01 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Redfund Capital Corp. Condensed interim consolidated financial statements For the nine months ended June 30, 2020 Unaudited – Prepared by Management'. It contains detailed financial statements including statements of financial position, changes in shareholders' equity, and statements of loss and comprehensive loss for the three and nine months ended June 30, 2020 and 2019. The document is unaudited and prepared by management, consistent with an interim or quarterly report. The presence of substantive financial data and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement. Therefore, the correct classification is Interim / Quarterly Report (IR). 9M 2020
2020-09-01 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the ramp-up of production and new product launch by a portfolio client of Redfund Capital Corp. It contains promotional and business update information about product flavors, market plans, and company focus. There are no financial statements, regulatory filings, voting results, or management changes. The content is typical of a general corporate announcement or business update rather than a formal financial or regulatory report. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. Given the nature and content, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other specific categories.
2020-08-03 English
News release - English.pdf
Regulatory Filings
2020-07-29 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing a new distribution agreement between Redfund Capital Corp. and Hempfy Switzerland. It discusses business expansion and product distribution but does not contain financial statements, regulatory filings, or detailed financial data. It is a corporate announcement about a business development rather than a formal financial report or regulatory filing. The document length is 4322 characters, which is relatively short and typical for a press release. There is no indication that this is an Annual Report, Earnings Release, or any other formal filing type. It does not fit into categories like M&A, Capital Update, or Board changes. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements and press releases that do not fit other categories.
2020-07-22 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.